Irreversible pulpitis (dental). Other diseases of pulp and periapical tissues
Conditions
Interventions
Intervention 1: Intervention group: material in use: Diclofenac, delivery system: mucosal patch (produced by Shahid Beheshti pharmacy school), drug concentration in each patch: 1% (may alter during dr
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients who are between 18 and 65 years old. Patients whose physical status is classified as Class I American Society of Anesthesiologists (ASA) Maxillary and mandibular first or second molar with irreversible pulpitis diagnosis. Subjects who have no swelling or fistula. Patients with positive response to electrical pulp testing and prolonged mild to moderate pain following cold pulp test confirming an irreversible pulpitis diagnosis for each tooth.
Exclusion criteria
Exclusion criteria: Subjects with any systemic disorder, gastrointestinal disease or allergy that interferes with diclofenac. Patients who are allergic to local anesthesia drugs or sulfite. Subjects with a teeth that can not be restorated or teeth with severe periodontal disease which are not suitable for endodontic treatment. Patients who have taken any analgesic medication 12 hours prior to the appointment. Patients who are not in a position to give informed consent. Patients who are unable to read or write. Patients with spontaneous pain requiring emergency treatment. Women pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity after root canal treatment. Timepoint: Pain measurement immediately after root canal treatment and 2, 4, 8, 24, 48, 72 hours after the treatment. Method of measurement: Numeric Rating Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeede Zadsirjan
Shahid Beheshti University of Medical Sciences
Outcome results
None listed